Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Defibrotide Sodium A medication used to treat and prevent a rare and ...
Defibrotide Gene Therapy Photograph by Wladimir Bulgar/science Photo ...
Full article: Recent developments with defibrotide for the treatment of ...
Figure 1 from Defibrotide for Treatment of Severe Veno-Occlusive ...
Defibrotide in the treatment of hepatic veno-occlusive disease | HMER
(PDF) Defibrotide for Treatment of Severe Veno-Occlusive Disease in ...
Real-World Outcome of Defibrotide Treatment for Severe Hepatic Veno ...
Real-world use of defibrotide for veno-occlusive disease/sinusoidal ...
(PDF) Defibrotide in the treatment of hepatic veno-occlusive disease
(PDF) Recent developments with defibrotide for the treatment of hepatic ...
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease ...
Analysis of Time to Complete Response after Defibrotide Initiation in ...
Defibrotide Prophylaxis after Second Hematopoietic Cell Transplant in ...
Systematic review of defibrotide studies in the treatment of veno ...
Treatment Duration, Symptom Resolution, and Survival in Defibrotide ...
Table 1 from Defibrotide for the treatment of hepatic veno-occlusive ...
A Systematic Review and Meta-Analysis of Studies of Defibrotide ...
Successful defibrotide treatment of a patient with veno-occlusive ...
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive ...
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease ...
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final ...
Escalation to High Dose Defibrotide in Patients with Hepatic Veno ...
Defibrotide Treatment: Uses, Dosage & Side Effects Explained - The ...
Successful defibrotide treatment of a patient with veno-occl... : Medicine
Key Phase I/II clinical trials of defibrotide for treatment of ...
(PDF) Phase 3 trial of defibrotide for the treatment of severe veno ...
Final results from a defibrotide treatment‐IND study for patients with ...
Defibrotide « New Drug Approvals
Frontiers | Defibrotide modulates pulmonary endothelial cell activation ...
Defibrotide Interferes With Several Steps of the Coagulation ...
(PDF) Defibrotide for the prevention of hepatic veno‐occlusive disease ...
Defibrotide for the treatment of hepatic veno‐occlusive disease in ...
(PDF) Real-world use of defibrotide for veno-occlusive disease ...
Figure 2 from Defibrotide for prophylaxis of hepatic veno-occlusive ...
Defibrotide | Arteriosclerosis, Thrombosis, and Vascular Biology
Figure 1 from Defibrotide for prophylaxis of hepatic veno-occlusive ...
Timing of initiation of defibrotide (DF) post-diagnosis of hepatic veno ...
(PDF) Defibrotide for prophylaxis of hepatic veno-occlusive disease in ...
(PDF) Earlier defibrotide initiation post-diagnosis of veno-occlusive ...
Figure 1 from Risk factors analysis and defibrotide efficacy in the ...
Defibrotide for Protecting Against and Managing Endothelial Injury in ...
(PDF) Defibrotide as salvage therapy for refractory veno-occlusive ...
(PDF) Low, fixed dose defibrotide in management of hepatic veno ...
(PDF) Safety and efficacy of defibrotide for the treatment of severe ...
Early defibrotide therapy and risk factors for post‐transplant veno ...
Restrictive Defibrotide Prophylaxis Guidelines Decrease Expenditure and ...
Timing of initiation of defibrotide after VOD/SOS diagnosis. MOD ...
Defibrotide - PMC
Defibrotide - wikidoc
Bleeding rates for IV defibrotide (A) and controls regardless of route ...
(PDF) Defibrotide
Defibrotide inhibits human peripheral blood MNC and T cell migration ...
The use of defibrotide in blood and marrow transplantation - PMC
Defibrotide acts as a PI3/AKT inhibitor to interact with HDACs. A ...
Defibrotide impact on the acute GVHD disease incidence in pediatric ...
Defibrotide inhibits donor leucocyte‐endothelial interactions and ...
Frontiers | Pre-Exposure to Defibrotide Prevents Endothelial Cell ...
Clinical Outcomes of Early Defibrotide Discontinuation: A Single-Center ...
Safety/tolerability data for defibrotide in Phase III clinical studies ...
Pharmacokinetic profile of defibrotide in patients with renal impairme ...
Pharmacokinetic profile of defibrotide in patients with renal ...
DailyMed - DEFITELIO- defibrotide sodium injection, solution
Jazz Pharmaceuticals to Present Data on Defibrotide for Patients with ...
Defibrotide (DF) inhibits in vitro angiogenesis, using the AngioKit TM ...
Defibrotide Therapy for SARS-CoV-2 ARDS - CHEST
Defibrotide prevents HDAC1 increased expression induced by CKD sera in ...
Defibrotide (DF) modulates the invasive potential of multiple myeloma ...
DESIGN OF PHASE 3, RANDOMIZED TRIAL OF DEFIBROTIDE FOR PREVENTION ...
| Defibrotide (DF) suppresses endothelial cell (EC) tube formation ...
A phase II, prospective, randomized, open-label study of defibrotide ...
Jazz Pharmaceuticals Announces FDA Approval of Defitelio® (defibrotide ...
Defitelio (Defibrotide Sodium for Intravenous Use): Uses, Dosage, Side ...
Defibrotide: real-world management of veno-occlusive disease/sinusoidal ...
Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and ...
Table 1 from Treatment of severe veno-occlusive disease with ...
Frontiers | Operational procedure sharing pathway in veno-occlusive ...
The importance of endothelial protection: the emerging role of ...
Defitelio (Defibrotide Sodium): First Drug Approved for Patients with ...
Defitelio® (defibrotide sodium) | Diagnostic Criteria for VOD/SOS
NDC 68727-800 Defitelio Injection, Solution Intravenous
Defitelio (defibrotide去纤苷钠)用于肝窦阻塞综合征中文说明书|香港济民药业 【药品名称】：Defitelio(去纤维钠 ...
Multiplex Proteomics in the Identification of Potential Biomarkers of ...
Frontiers | Emerging therapeutic strategies targeting extracellular ...
